Don't let the Slippery Slope of Volatility Scare you from Biotechs
Excited By the Potential, But Unclear Where To Begin...
We Can Help!
A Biotech Stock Portfolio That Combines ...
Prudence
Our time-tested system sifts through biotech companies, analyzing them on a variety of criteria, eliminating ideas which don’t pass our parameters, and eventually creating a ranking structure for a pool of ideas, which best exemplify our risk and reward considerations. The portfolio risk is further managed through adequate diversification. The key to success is the Discipline to pursue a proven system, and not second-guess.
Patience
Wealth-building requires Patience. We give room for the ideas to work and the portfolio to grow. Based on our monthly updates, you simply maintain the positions. When a position is closed, you reinvest the proceeds. Just a plant takes time to grow into a tree, so will your portfolio.
Performance
Through a combination of Prudence and Patience, we are able to deliver market-trouncing Performance. Biotech is a sector of great promise and great volatility. We follow our system with great discipline, which allows us to, first, prudently manage the risk and, second, unleash the rewards. This breeds Consistency.
- Eric Rosen
I have had my share of hits-and-runs in Biotech. Very stressful. But it was hard to make money consistently. I'm so happy to discover your newsletter. Thanks a million (no pun intended) đ !
What do you Get?
-
1
A Monthly Edition of the Prudent Biotech Portfolio
Instant access to our Members Only current and recent issues. The edition has our recommended portfolio for the month, clearly laid out for subscribers. Simply keep track of the guidance at the beginning of the month, and then you're done for the month. No need to track ideas daily. This product is particularly suitable for millennial and DIY investors who wish to be relatively active managers of their portfolio, without the time-consuming daily follow-ups and constant research.
-
2
A Complete Model Driven Investing Approach
Remember, that the portfolio represents access to a quantitative model-based investing methodology. If you're tired of Buy-and-Hope investing, and believe in the merits of systematic, emotionless investing, then our approach delivers what you're looking for. Remember patience and discipline are the bedrock of a successful investment strategy. Learn more here.
-
3
An Awesome Guarantee
We have worked hard in creating a quality product, and will continue to do so. You decide on the best subscription deal that works for you. But we realize, that once you make the choice you may like to have the flexibility of a no-risk trial period. You got it! If for any reason you would like a refund, you can decide comfortably over the next 2 months. Yes, a 60-day full money-back guarantee, with no questions asked. Now, it's all up to you.
-
4
Bonus eBook
With your subscription today, you will receive a Free eBook on XXXXXX
Pricing & Risk-Free Money Back Guarantee
100% Risk Free, 60 Days Money Back Guarantee
We will do our best to provide you with an excellent product to contribute towards your wealth-building goals through disciplined investing. We back this with our guarantee that if you are unsatisfied for any reason with the subscription, you can cancel at any time within 60-days of your Sign Up for a full refund. No questions asked. So try it out without refund worries and see if the product can contribute to your financial goals.
Interested in a Free Sample Issue?
We value your privacy and would never spam you
Would You Like A FREE Monthly Stock Pick?
A pick from our portfolio delivered monthly to your mailbox.
We value your privacy and would never spam you
Graycell Advisors, and its affiliates, officers, employees, families, and all other related parties, collectively referred to as âGraycellâ and/or âwe,â is a publisher of financial information, such as the Prudent Biotech newsletter. Historical performance figures provided are hypothetical, unaudited and prepared by us, based on our proprietary analysis and system performance, back-tested over an extended period of time. The performance results obtained are intended for illustrative purposes only. Past performance is not indicative of future results, which may vary. All stock and related investments have a degree of risk, which can result in significant or total loss. In addition, biotech sector is characterized by much higher risk and volatility than the general stock market. Information contained herein does not constitute a personal recommendation or takes into account the particular investment objectives, financial situations, or needs of individual investors. If you decide to invest in any of the stocks of the companies mentioned in the newsletters, samples, alerts, etc., sent to you or available on our websites, you can and may lose some or all of your investment. You alone are responsible for your own investment decisions. We are not liable nor do we assume any responsibility for losses incurred as a result of any information provided or not provided or not made available in a timely manner, herein or on our website or using any other medium. Â We also cannot guarantee the accuracy and completeness of any information furnished by us. Graycell is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. We may or may not already have existing positions in the stocks mentioned in our reports. Our models are proprietary and/or licensed, and can be changed or revised based on our discretion at any time without any notification. Subscribers and investors should always conduct their own due diligence with any potential investment, and consider obtaining professional advice before making an investment decision.